Purification and Characterization of Mast Cell Tryptase and Chymase from Human Tissues
* Final gross prices may vary according to local VAT.Get Access
Mast cells are key effector cells of the allergic response. When stimulated by specific allergen through the high-affinity IgE receptors or through other stimuli, these cells release a number of potent mediators of inflammation. Amongst these are the serine proteases tryptase and chymase. In humans, tryptase is the most abundant mediator stored in mast cells. Chymase is present in more moderate amounts in a subpopulation of mast cells (MCTC). This subtype of mast cells predominates in connective tissue, whereas the other major subtype, the MCT, predominates in mucosal tissue.
Both proteases have been shown to act on specific extracellular proteins and peptides, as well as to alter the behavior of various cell types. Inhibitors of tryptase have been found to be efficacious in animal and human models of asthma, and both proteases are currently being investigated as potential targets for therapeutic intervention. Such pharmacological, physiological, and biochemical studies require the availability of purified tryptase and chymase.
In this chapter, we shall describe procedures for the purification of tryptase and chymase from human tissues and provide protocols for monitoring purification and characterization of the final product. The preparation of recombinant proteases will not be covered, though some of the procedures described may be readily adapted for their purification from recombinant expression systems. The procedures described here have been developed for the purification of the human proteases and will require some modification if applied to purify mast cell proteases from the tissues of other species.
- Walls, A. F. (2000) The roles of neutral proteases in asthma and rhinitis. In Asthma and Rhinitis (Busse, W. W. and Holgate, S. T., eds), Blackwell, Boston, pp. 968–998.
- Beil, W. J., Schulz, M., McEuen, A. R., Buckley, M. G., and Walls, A. F. (1997) Number, fixation properties, dye-binding and protease expression of duodenal mast cells: comparisons between healthy subjects and patients with gastritis or Crohn’s disease. Histochem. J. 29, 759–773. CrossRef
- Beil, W. J., McEuen, A. R., Schulz, M., et al. (2003) Selective alterations in mast cell subsets and eosinophil infiltration in two complementary types of intestinal inflammation: ascariasis and Crohn’s disease. Pathobiology 70, 303–313. CrossRef
- Walls, A. F. (2000) Structure and function of human mast cell tryptase. In Mast Cells and Basophils (Marone, G., Lichtenstein, L. M., and Galli, S. J., eds), Academic Press, New York, pp. 291–309. CrossRef
- Walls, A. F. (2001) Tryptase inhibitors. In Therapeutic Immunology (Austen, K. F., Burakoff, S. J., Rosen, F. S., and Strom, T. B., eds), 2nd edition, Blackwell, Boston, pp. 150–158.
- Krishna, M. T., Chauhan, A., Little, L., et al. (2001) Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J. Allergy Clin. Immunol. 107, 1039–1045. CrossRef
- Peng, Q., McEuen, A. R., Benyon, R. C., and Walls, A. F. (2003) The heterogeneity of mast cell tryptase from human lung and skin-differences in size, charge and substrate affinity. Eur. J. Biochem. 270, 270–283. CrossRef
- McEuen, A. R., GaÇa, M. D. A., Buckley, M. G., et al. (1998) Two distinct forms of human mast cell chymase. Differences in affinity for heparin and in distribution in skin, heart, and other tissues. Eur. J. Biochem. 256, 461–470. CrossRef
- Schechter, N. M., Fräki, J. E., Geesin, J. C., and Lazarus, G. S. (1983) Human skin chymotryptic proteinase. Isolation and relation to cathepsin G and rat mast cell proteinase I. J. Biol. Chem. 258, 2973–2978.
- Schechter, N. M., Choi, J. K., Slavin, D. A., et al. (1986) Identification of a chymotrypsin-like proteinase in human mast cells. J. Immunol. 137, 962–970.
- McEuen, A. R., Sharma, B., and Walls, A. F. (1995) Regulation of the activity of human chymase during storage and release from mast cells: the contributions of inorganic cations, pH, heparin and histamine. Biochem. Biophys. Acta 1267, 115–121. CrossRef
- He, S. and Walls, A. F. (1998) The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur. J. Pharmacol. 352, 91–98. CrossRef
- He, S. and Walls, A. F. (1998) Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br. J. Pharmacol. 125, 1491–1500. CrossRef
- Schwartz, L. B., Bradford, T. R., Lee, D. C., and Chlebowski, J. F. (1990) Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer. J. Immunol. 144, 2304–3211.
- He, S., Peng, Q., and Walls, A. F. (1997) Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase. Selective enhancement of eosinophil recruitment by histamine. J. Immunol. 159, 6216–6225.
- Stack, M. S. and Johnson, D. A. (1994) Human mast cell tryptase activates singlechain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269, 9416–9419.
- Walls, A. F., Bennett, A. R., McBride, H. M., et al. (1990) Production and characterisation of monoclonal antibodies specific for human mast cell tryptase. Clin. Exp. Allergy 20, 581–589. CrossRef
- Schechter, N. M., Jordan, L. M., James, A. M., et al. (1993) Reaction of human chymase with reactive site variants of α1-antichymotrypsin. Modulation of inhibitor versus substrate properties. J. Biol. Chem. 268, 23,626–23,633.
- Smith, T. H., Hougland, M. W., and Johnson, D. A. (1984) Human lung tryptase. Purification and characterization. J Biol. Chem. 259, 11,046–11,051.
- McEuen, A. R., He, S., Brander, M. L., and Walls, A. F. (1996) Guinea pig lung tryptase: localisation to mast cells and characterisation of the partially purified enzyme. Biochem. Pharmacol. 52, 331–340. CrossRef
- Compton, S. J., Cairns, J. A., Holgate, S. T., and Walls, A. F. (1998) The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release and adhesion molecule expression. Tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J. Immunol. 161, 1939–1946.
- Berger, P., Perng, D.-W., Thabrew, H., et al. (2001) Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J. Appl. Physiol. 91, 1372–1379.
- Purification and Characterization of Mast Cell Tryptase and Chymase from Human Tissues
- Book Title
- Allergy Methods and Protocols
- pp 299-317
- Print ISBN
- Online ISBN
- Series Title
- Methods in Molecular Medicine
- Series Volume
- Series ISSN
- Humana Press
- Copyright Holder
- Humana Press
- Additional Links
- mast cell
- Industry Sectors
- Editor Affiliations
- 1. Department of Occupational and Environmental Medicine, Imperial College
- 2. St. George’s University of London
- Author Affiliations
- 3. Immunopharmacology Group, Southampton General Hospital, Southampton, UK
To view the rest of this content please follow the download PDF link above.